Matthew L. Kaplan, Director of Nuvectis Pharma NVCT, has filed 1 purchase and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $64.2K. The latest trade was on 06/11.

MK

MK

Matthew L. Kaplan

Director

Company

Nuvectis Pharma NVCT

First filing

23/06/20

Trades

5 trades

Buys / sales

1 / 0

12-month net buying

$64.2K

Last trade

06/11

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Nuvectis PharmaNVCT	Open-market buy	25/11/05	25/11/06	11,000 sh	$5.84	$64,240	+9.7%